FDA Focuses Workshop On Diabetes Device Software
This article was originally published in The Gray Sheet
The agency's Nov. 13 public workshop on software for diabetes management will focus on diabetes device interoperability and technical considerations for insulin bolus calculator design and use.
You may also be interested in...
An FDA draft guidance issued earlier this year on hospital glucose meters has attracted an unusual amount of attention, including criticism from clinicians, companies and others who worry it could cut off access to point-of-care glucose testing in patient cases where it is needed. The agency says it is taking appropriate measures to address a safety issue, and that some of the criticism is misdirected.
Japanese big pharma Eisai taps Celgene and Sanofi execs as its new VPs for corporate affairs and market access. And Freeline Therapeutics, developer of gene therapies for bleeding disorders, selects a former Alnylam Pharma SVP as CEO.